A federal appeals court on Friday affirmed the dismissal of more than a thousand lawsuits by men who used Pfizer Inc testosterone replacement drug Depo-T, finding the claims were preempted by U.S. Food and Drug Administration approval of the medicationâ€™s label.
In a unanimous decision, a three-judge panel of the 7th Circuit U.S. Court of Appeals ruled that U.S. District Judge Matthew Kennelly, who oversees the multidistrict litigation over Depo-T and similar drugs, correctly dismissed the lawsuits in 2015.
To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2DqBVz1
 